CN104120166A - Method and kit for detecting mutation of PDS gene 2168A>G by using fluorescence PCR technology - Google Patents
Method and kit for detecting mutation of PDS gene 2168A>G by using fluorescence PCR technology Download PDFInfo
- Publication number
- CN104120166A CN104120166A CN201310142789.XA CN201310142789A CN104120166A CN 104120166 A CN104120166 A CN 104120166A CN 201310142789 A CN201310142789 A CN 201310142789A CN 104120166 A CN104120166 A CN 104120166A
- Authority
- CN
- China
- Prior art keywords
- pds gene
- probe
- wild
- type
- type probe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101150108119 PDS gene Proteins 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000035772 mutation Effects 0.000 title claims abstract description 15
- 238000005516 engineering process Methods 0.000 title abstract description 5
- 239000000523 sample Substances 0.000 claims abstract description 92
- 238000006243 chemical reaction Methods 0.000 claims abstract description 23
- 230000003321 amplification Effects 0.000 claims abstract description 15
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 15
- 239000003086 colorant Substances 0.000 claims abstract description 7
- 238000003908 quality control method Methods 0.000 claims description 35
- 238000012360 testing method Methods 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- 238000013461 design Methods 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 239000007850 fluorescent dye Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 8
- 239000008280 blood Substances 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 238000003556 assay Methods 0.000 claims description 6
- 239000013600 plasmid vector Substances 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 5
- 241000972773 Aulopiformes Species 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 230000000869 mutational effect Effects 0.000 claims description 4
- 238000010791 quenching Methods 0.000 claims description 4
- 230000000171 quenching effect Effects 0.000 claims description 4
- 235000019515 salmon Nutrition 0.000 claims description 4
- -1 dNTP Substances 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 210000001776 amniocyte Anatomy 0.000 claims description 2
- 238000003752 polymerase chain reaction Methods 0.000 claims description 2
- 210000003296 saliva Anatomy 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 206010011878 Deafness Diseases 0.000 abstract description 11
- 210000002905 vestibular aqueduct Anatomy 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 208000011580 syndromic disease Diseases 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 abstract 3
- 206010010356 Congenital anomaly Diseases 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 239000013062 quality control Sample Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 31
- 108020004414 DNA Proteins 0.000 description 10
- 238000001514 detection method Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 238000007400 DNA extraction Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000007018 DNA scission Effects 0.000 description 2
- 241001643597 Evas Species 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 102000011384 Pendrin Human genes 0.000 description 2
- 108050001616 Pendrin Proteins 0.000 description 2
- 102100035278 Pendrin Human genes 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000370738 Chlorion Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 206010011882 Deafness congenital Diseases 0.000 description 1
- 206010011891 Deafness neurosensory Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010014016 Ear malformation Diseases 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108091006507 SLC26A4 Proteins 0.000 description 1
- 101150030803 SLC26A4 gene Proteins 0.000 description 1
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000879 sensorineural hearing loss Toxicity 0.000 description 1
- 208000023573 sensorineural hearing loss disease Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310142789.XA CN104120166A (en) | 2013-04-24 | 2013-04-24 | Method and kit for detecting mutation of PDS gene 2168A>G by using fluorescence PCR technology |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310142789.XA CN104120166A (en) | 2013-04-24 | 2013-04-24 | Method and kit for detecting mutation of PDS gene 2168A>G by using fluorescence PCR technology |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104120166A true CN104120166A (en) | 2014-10-29 |
Family
ID=51765796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310142789.XA Pending CN104120166A (en) | 2013-04-24 | 2013-04-24 | Method and kit for detecting mutation of PDS gene 2168A>G by using fluorescence PCR technology |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104120166A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104711367A (en) * | 2015-04-03 | 2015-06-17 | 济南英盛生物技术有限公司 | Multichannel fluorescent PCR detection kit of delayed deafness gene |
CN106929608A (en) * | 2017-05-04 | 2017-07-07 | 张家港蓝苏生物工程有限公司 | A kind of fluorescence PCR method and kit of specific detection rubella virus nucleic acid |
CN107058538A (en) * | 2017-04-20 | 2017-08-18 | 昆明理工大学 | The kit and application of a kind of Primer composition and its composition |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102108412A (en) * | 2010-12-22 | 2011-06-29 | 协和干细胞基因工程有限公司 | Kit for detecting susceptibility of large vestibular aqueduct syndrome epicophosis |
CN102108410A (en) * | 2010-12-22 | 2011-06-29 | 协和干细胞基因工程有限公司 | Gene combinations, primer, probe and applications thereof for determining PDS gene mutation of large vestibular aqueduct syndrome deafness |
CN102465174A (en) * | 2010-11-09 | 2012-05-23 | 王宝恒 | Method for detecting GJB2 gene mutation by fluorescence quantitative PCR technology, and kit thereof |
CN102719538A (en) * | 2012-06-07 | 2012-10-10 | 上海交通大学 | Gene chip for non-invasive prenatal diagnosis of high-risk hereditary hearing loss and preparation method |
CN102864232A (en) * | 2012-09-26 | 2013-01-09 | 潮州凯普生物化学有限公司 | Deafness susceptive gene joint detection kit |
-
2013
- 2013-04-24 CN CN201310142789.XA patent/CN104120166A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102465174A (en) * | 2010-11-09 | 2012-05-23 | 王宝恒 | Method for detecting GJB2 gene mutation by fluorescence quantitative PCR technology, and kit thereof |
CN102108412A (en) * | 2010-12-22 | 2011-06-29 | 协和干细胞基因工程有限公司 | Kit for detecting susceptibility of large vestibular aqueduct syndrome epicophosis |
CN102108410A (en) * | 2010-12-22 | 2011-06-29 | 协和干细胞基因工程有限公司 | Gene combinations, primer, probe and applications thereof for determining PDS gene mutation of large vestibular aqueduct syndrome deafness |
CN102719538A (en) * | 2012-06-07 | 2012-10-10 | 上海交通大学 | Gene chip for non-invasive prenatal diagnosis of high-risk hereditary hearing loss and preparation method |
CN102864232A (en) * | 2012-09-26 | 2013-01-09 | 潮州凯普生物化学有限公司 | Deafness susceptive gene joint detection kit |
Non-Patent Citations (1)
Title |
---|
王默进等: "运用TaqMan 探针实时荧光PCR技术检测AKAP10 基因2073A/G单核苷酸多态性", 《四川大学学报》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104711367A (en) * | 2015-04-03 | 2015-06-17 | 济南英盛生物技术有限公司 | Multichannel fluorescent PCR detection kit of delayed deafness gene |
CN104711367B (en) * | 2015-04-03 | 2016-06-22 | 济南英盛生物技术有限公司 | A kind of Delayed onset deaf gene multichannel fluorescence PCR detection reagent kit |
CN107058538A (en) * | 2017-04-20 | 2017-08-18 | 昆明理工大学 | The kit and application of a kind of Primer composition and its composition |
CN107058538B (en) * | 2017-04-20 | 2021-01-19 | 昆明理工大学 | Primer composition, kit composed of primer composition and application of kit |
CN106929608A (en) * | 2017-05-04 | 2017-07-07 | 张家港蓝苏生物工程有限公司 | A kind of fluorescence PCR method and kit of specific detection rubella virus nucleic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Switaj et al. | Recent trends in molecular diagnostics for Toxoplasma gondii infections | |
US8980555B2 (en) | Rapid genotyping analysis and devices thereof | |
Costa et al. | Genotyping of the protozoan pathogen Toxoplasma gondii using high-resolution melting analysis of the repeated B1 gene | |
CN107254531B (en) | Genetic biomarker for auxiliary diagnosis of early colorectal cancer and application thereof | |
WO2014139330A1 (en) | Rapid genotyping analysis and kits thereof | |
CN102465174A (en) | Method for detecting GJB2 gene mutation by fluorescence quantitative PCR technology, and kit thereof | |
CN102534031A (en) | High-specificity kit for detecting deafness predisposing genes | |
EP2964780B1 (en) | Discrimination of blood type variants | |
CN110699446B (en) | SNP marker rs3174298 related to non-syndrome cleft lip and palate diagnosis and application thereof | |
CN106521023A (en) | Kit and method for detecting HPFH and delta beta-thalassemia of Chinese people | |
EP2130917A1 (en) | Probe for detecting polymorphism in gene involved in immunity, and use thereof | |
CN106834434B (en) | Nucleic acid, kit and method for detecting COX-1, COX-2 and GPIIIa gene polymorphism | |
CN105441540A (en) | Non-syndromic deafness gene polymorphism detecting kit and application thereof | |
CN111676283A (en) | Application of mitochondrial DNA single nucleotide polymorphism related to occurrence of high altitude pulmonary edema | |
CN104120166A (en) | Method and kit for detecting mutation of PDS gene 2168A>G by using fluorescence PCR technology | |
Ramezanzadeh et al. | Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment | |
CN115029444A (en) | Molecular marker related to sheep growth traits and application thereof | |
CN109182493A (en) | The primer and kit and its detection method of people's 16p11.2 microdeletion syndrome detection | |
CN104120167A (en) | Method and kit for detecting mutation of PDS gene IVS7-2A>G by using fluorescence PCR technology | |
US20070128602A1 (en) | Polynucleotide associated with a colon cancer comprising single nucleotide poylmorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide | |
CN104789673B (en) | Applications of the rs1800818 in heating companion's thrombocytopenic syndromes that new bunyavirus causes are detected | |
CN102534030A (en) | Kit for jointly detecting four deafness predisposing genes and application thereof | |
CN104099402A (en) | Method for detecting GJB2 gene 235delC mutation by employing single-tube fluorescence PCR technology and kit thereof | |
Şuteu et al. | Molecular detection of Neospora caninum in slaughtered goat kids from Romania | |
EP2840147A1 (en) | Method for assessing endometrial cancer susceptibility |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHI GUIZHI Free format text: FORMER OWNER: WANG BAOHENG Effective date: 20150807 Owner name: WANG BAOHENG Effective date: 20150807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Shi Guizhi Inventor after: Wang Baoheng Inventor before: Wang Baoheng Inventor before: Shi Guizhi |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG BAOHENG SHI GUIZHI TO: SHI GUIZHI WANG BAOHENG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150807 Address after: 250002, room 2, building 9, building 501, provincial court dormitory, sunshine Shun two district, Shizhong District, Ji'nan City, Shandong Applicant after: Shi Guizhi Applicant after: Wang Baoheng Address before: 250002, room 2, building 9, building 501, provincial court dormitory, sunshine Shun two district, Shizhong District, Ji'nan City, Shandong Applicant before: Wang Baoheng |
|
DD01 | Delivery of document by public notice |
Addressee: Shi Guizhi Document name: the First Notification of an Office Action |
|
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141029 |
|
WD01 | Invention patent application deemed withdrawn after publication |